I am a board-certified renal (kidney) specialist who provides consultations and follow-up care for Memorial Sloan Kettering outpatients and inpatients, as well as for patients in our critical care unit. Our team provides the full spectrum of renal replacement therapy for hospitalized patients.
My areas of interest include fluid and electrolyte disturbances, hypertension, the renal toxicity of chemotherapeutic agents, and the management of critically ill patients who are experiencing renal failure. I have lectured across the United States about sodium balance disorders, and have authored publications on such topics as the use of chemotherapy during hemodialysis (a renal replacement therapy) and the development of fluid and electrolyte disturbances in cancer patients.
Currently, I am a principal investigator in a clinical trial examining the use of an extracorporeal (outside the body) therapy in patients with sepsis — bacteria (or their toxins) in the blood or tissues.
- Clinical Expertise: Clinical Nephrology; Hypertension; Electrolyte Disturbances; Renal Imaging
- Languages Spoken: English
- Education: MD, Stony Brook University School of Medicine
- Residencies: North Shore University Hospital
- Fellowships: North Shore University Hospital
- Board Certifications: Internal Medicine; Nephrology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more